Comparison of Cardiovascular Risk of Noncardiac Surgery Following Coronary Angioplasty With Versus Without Stenting

Leibowitz, David; Cohen, Marc; Planer, David; Mosseri, Morris; Rott, David; Lotan, Chaim; Weiss, A. Teddy

doi:10.1016/j.amjcard.2005.11.037

Cited by 38 publications

(19 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Leibowitz et al 314 performed a retrospective review of 216 patients who had PCI with balloon angioplasty alone or PCI with stenting within 3 months of noncardiac surgery. Adverse clinical events included acute MI, major bleeding, and death less than 6 months after noncardiac surgery.…”

Section: Pci Without Stents: Coronary Balloon Angioplastymentioning

confidence: 99%

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

Fleisher¹,

Beckman²,

Brown³

et al. 2007

Circulation

625

281

View full text Add to dashboard Cite

Section: Pci Without Stents: Coronary Balloon Angioplastymentioning

confidence: 99%

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

Fleisher¹,

Beckman²,

Brown³

et al. 2007

Circulation

625

281

View full text Add to dashboard Cite

“…[42][43][44][45][46][47][48][49] On the basis of the available literature, delaying noncardiac surgery for more than 8 weeks after balloon angioplasty increases the chance that restenosis at the angioplasty site will have occurred and theoretically increases the chances of perioperative ischemia or MI. However, performing the surgical procedure too soon after the PCI procedure might also be hazardous.…”

Section: Pci Without Stents: Coronary Balloon Angioplastymentioning

confidence: 99%

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary

Fleisher¹,

Beckman²,

Brown³

et al. 2007

Circulation

583

138

View full text Add to dashboard Cite

“…While the CARP was limited by: 1) the study excluded patients with symptoms of unstable coronary disease, left main CAD, aortic stenosis, or severe left ventricular dysfunction, which are Class I indications for CABG based on American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for CABG surgery published in 2004 (42); and 2) the group of coronary revascularization in this study was mixed with 2 different techniques: CABG and PCI. However, several studies have already demonstrated a high incidence of cardiovascular complications when noncardiac surgery is performed shortly after PCI (43)(44)(45). Actually, in the substudy of the CARP trial, Ward et al compared clinical outcomes in the patients receiving CABG vs. PCI as prophylaxis for elective vascular surgery and found that compared with the patients with PCI (131 patients), the patients with CABG (91 patients) had fewer MIs despite more diseased vessels in the CABG group and tended to spend less time in the hospital after the vascular operation.…”

Section: Coronary Revascularization Before Noncardiac Surgerymentioning

confidence: 99%

Evidence for Preoperative Aspirin Improving Major Outcomes in Patients With Chronic Kidney Disease Undergoing Cardiac Surgery

Yao¹,

Young²,

Liu³

et al. 2015

Annals of Surgery

View full text Add to dashboard Cite

Aim of review:Diabetes is a chronic and slowly progressing disease that has a tendency to develop rapidly deteriorating complications such as major adverse cardiovascular events (MACE), especially under the stress of surgery. While clinical strategy to prevent MACE is controversial and uncertain. Method: We conducted a comprehensive review of current clinical strategies in preventing perioperative MACE, in particularly related to diabetic patients. Results: The major findings are: 1) Current clinical studies have demonstrated that coronary artery bypass graft (CABG) is still a better therapy than percutaneous coronary intervention (PCI) on the ground of reducing repeat revascularization, myocardial infarction and death for most diabetic patients with left main-stem and multivessel coronary artery disease who require revascularization, however, it remains to be studied whether coronary revascularization before noncardiac surgery can protect diabetic patients from MACE; 2) There is lack of evidence that intensive or "tight" glycemic control perioperatively can reduce MACE, instead, a moderate or less stringent glucose management probably is safer for patients undergoing surgery;3) The recent results of clinical trials on beta-blockers appear to be disappointing in preventing MACE in surgical patients, including diabetic patients. Meanwhile, the perioperative therapy with statins, angiotensin-converting enzyme inhibitors or multifactorial interventions is promising in preventing MACE in diabetic patients. Summary: Further studies targeted at preventing MACE in diabetic patients undergoing surgery are needed in order to fight this major health problem in perioperative medicine. ABSTRACT

show abstract

Comparison of Cardiovascular Risk of Noncardiac Surgery Following Coronary Angioplasty With Versus Without Stenting

Cited by 38 publications

References 9 publications

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary

Evidence for Preoperative Aspirin Improving Major Outcomes in Patients With Chronic Kidney Disease Undergoing Cardiac Surgery

Contact Info

Product

Resources

About